GlassScriptPhysician profile
Steven Krein
NPI 1841294766
$548.61
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $65.10 · 2021: $71.42 · 2022: $38.33 · 2023: $84.10 · 2024: $21.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $105.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $150.00 | 2019 | |
| Pacira Therapeutics, INC. | $82.10 | 2019-2021 | |
| Convatec INC. | $57.66 | 2021-2023 | |
| Linvatec Corporation | $40.30 | 2023-2024 | Biobrace 23mm, Allograft Tissue |
| Horizon Therapeutics Plc | $39.72 | 2020 | |
| Fx Shoulder Solutions, INC | $31.76 | 2019 | |
| Heron Therapeutics, INC. | $29.00 | 2022 | |
| Bioventus LLC | $28.66 | 2019-2021 | |
| Tactile Systems Technology INC | $19.72 | 2023 | Entre Plus, Flexitouch Plus |
| Smith+Nephew, INC. | $17.94 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.80 | 2019 | |
| Olympus America INC. | $13.81 | 2023 | Uretero-Reno Fiberscope |
| Ferring Pharmaceuticals INC. | $11.81 | 2020 | |
| Medela LLC | $9.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Krein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.